Eli Lilly eyes another stock split as shares top $1,000 in 2024
Eli Lilly’s share price has surged past $1,000 this year, rising by 32% so far. The pharmaceutical giant is now considering another stock market split to make its shares more accessible to investors. This move would follow its most recent split in 2022, part of a long-term strategy to maintain liquidity.
The company has a history of splitting its stock, with previous splits dating back to 1997. Since then, its share price has climbed dramatically. Stock splits do not change a company’s fundamentals but help keep share prices within a range that appeals to a broader group of investors. High-priced shares can become harder to trade, reducing liquidity, while lower-priced ones move more freely in the market.
With a stock price above $1,000 and a track record of splits, Eli Lilly appears well-positioned for another adjustment. The move would align with its strategy to sustain investor interest and trading activity. Meanwhile, its focus on innovation and AI-driven research continues to support long-term growth.
